B. Braun to Offer FDA-Approved Ceftriaxone in the Duplex Drug-Delivery System
BETHLEHEM, Pa. -- B. Braun Medical Inc. today announced that it received FDA approval for CefTRIaxONE in the DUPLEX® Drug Delivery System. The availability of CefTRIaxONE, a standard intravenous antibiotic preparation, helps clinicians comply with Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and USP <797> Guidelines that specify medicines should be dispensed in their "most ready-to-use form."
No admixing or thawing is required as each DUPLEX® Drug Delivery System comes complete with drug and diluent in a convenient ready-to-use bag stored at room temperature. With CefTRIaxONE in DUPLEX®, doses can be stored conveniently and are immediately available for emergency IV purposes. B. Braun is proud to have received approval for an additional drug, CefTRIaxONE in the DUPLEX® Drug Delivery System once the current patent expires.
DUPLEX® is a unique closed-system designed to simplify intravenous antibiotic delivery to patients, reduce the risk of medication errors, reduce drug waste and eliminate pharmacy labor required during IV antibiotic delivery preparation.
Features of the DUPLEX® Drug Delivery System for admixing include:
-- Closed system pre-filled with accurate drug and diluent doses in a sealed two-chamber IV bag. No hoods required
-- Caregiver simply squeezes bag to mix the drug and diluent at patient's bedside
--Barcode references final admixture to help ensure correct drug
-- Stores at room temperature
-- PVC-free, DEHP-free, and latex-free
-- Tall man labeling helps to differentiate the drugs in the Duplex Drug
Delivery System
The DUPLEX® System consists of a pre-filled, PVC-free, DEHP-free, and latex-free IV bag containing proper doses of drug and diluent in different compartments separated by a quick release seal. The caregiver simply squeezes the bag to mix the drug and diluent just prior to administration. The DUPLEX® System is equipped with a UCC/EAN-128 barcode that references the final admixture and can be used to reduce medication errors, automate patient charting, track inventory and facilitate reimbursement tracking.
Source: B. Braun
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
